The report finds that China has consolidated global dominance in the midstream stages of battery supply chains—refining and chemical conversion—giving the Chinese Communist Party significant influence over pricing, supply availability, and industrial investment.
This bipartisan letter from the Senate Banking Committee is a powerful signal that Congress is finally taking seriously what CPA has been warning about for years: the Chinese Communist Party has been exploiting America’s capital markets to fund its military modernization, underwrite its surveillance state, and enrich entities engaged in genocide, forced labor, and espionage — all with American investor capital.
The letter underscores a critical point: any effective policy response must address the entire solar supply chain—from polysilicon to ingots, wafers, cells, and finished modules—rather than focusing on a single segment in isolation.
Section 301 is a powerful tool for addressing foreign policies that distort global markets and disadvantage American producers. When foreign governments explicitly pursue overproduction and then export the resulting surplus into the United States, the effect is to displace domestic output and deter new investment in American manufacturing.
Section 301 actions against a particular country or group of countries are more likely to merely shift international supply chains as opposed to growing domestic productive output.
Last year, Americans spent more than $15 billion on Novo Nordisk’s diabetes and weight-loss drugs Ozempic and Wegovy. The active ingredient in both treatments — semaglutide— has rapidly become one of the world’s most commercially successful medicines.
For the first time, the new portal provides the American public with detailed access to reported foreign funding, including gifts and contracts from entities designated as “entities of concern” on nine federal government watchlists.
CPA urges the administration to move swiftly to deploy Section 232 investigations through the U.S. Department of Commerce as the most durable and effective tool available to restore American industrial capacity.
Today’s SCOTUS ruling should encourage the administration to refocus and expand its Section 232 efforts.
CPA strongly supports Senator Cassidy and Whitehouse’s Last Sale Valuation Act because it closes a long-standing loophole that has allowed multinational importers to artificially understate the value of goods entering the United States.
